| Ticker Details |
iRhythm Technologies, Inc.
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
|
| IPO Date: |
October 20, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Instruments and Equipment |
| Market Cap: |
$4.24B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.53 | 2.40%
|
| Avg Daily Range (30 D): |
$3.62 | 3.03%
|
| Avg Daily Range (90 D): |
$3.00 | 2.55%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.36M |
| Avg Daily Volume (30 D): |
.54M |
| Avg Daily Volume (90 D): |
.49M |
| Trade Size |
| Avg Trade Size (Sh.): |
52 |
| Avg Trade Size (Sh.) (30 D): |
44 |
| Avg Trade Size (Sh.) (90 D): |
44 |
| Institutional Trades |
| Total Institutional Trades: |
5,023 |
| Avg Institutional Trade: |
$3.31M |
| Avg Institutional Trade (30 D): |
$5.1M |
| Avg Institutional Trade (90 D): |
$4.9M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.38M |
| Avg Closing Trade (30 D): |
$7.77M |
| Avg Closing Trade (90 D): |
$7.88M |
| Avg Closing Volume: |
39.38K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.42
|
$-.01
|
$-.43
|
|
Diluted EPS
|
$-.42
|
$-.01
|
$-.43
|
|
Revenue
|
$825.34M
|
$224.17M
|
$199.39M
|
|
Gross Profit
|
$589.74M
|
$163.21M
|
$141.35M
|
|
Net Income / Loss
|
$-13.95M
|
$-.38M
|
$-13.93M
|
|
Operating Income / Loss
|
$-24.87M
|
$-2.54M
|
$-16.19M
|
|
Cost of Revenue
|
$235.6M
|
$60.97M
|
$58.04M
|
|
Net Cash Flow
|
$-62.41M
|
|
|
|
PE Ratio
|
|
|
|
|
|
|